SenesTech, Inc. (SNES) Marketing Mix

SenesTech, Inc. (SNES): Marketing Mix Analysis [Dec-2025 Updated]

US | Basic Materials | Chemicals - Specialty | NASDAQ
SenesTech, Inc. (SNES) Marketing Mix

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

SenesTech, Inc. (SNES) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

You're looking for the real story behind SenesTech, Inc.'s recent performance, not just press release fluff, and honestly, that 43% revenue surge they posted isn't an accident; it's the direct result of a finely tuned marketing engine. This is where the rubber meets the road. We've broken down their entire 4Ps strategy-from the Evolve® products driving 85% of Q3 2025 sales to their e-commerce channel capturing 54% of revenue-to show you exactly how they're winning market share against established competitors. Stick with me below to see the precise Product, Place, Promotion, and Price levers SenesTech, Inc. is pulling right now.


SenesTech, Inc. (SNES) - Marketing Mix: Product

You're looking at the core of what SenesTech, Inc. sells, and right now, the story is all about the shift to the Evolve line. As of the third quarter of 2025, the Evolve® Rat and Evolve® Mouse products are the primary revenue drivers, accounting for a commanding 85% of Q3 2025 sales. This dominance shows you where the market is moving, away from the older formulation.

The core offering from SenesTech, Inc. is non-toxic, humane, and sustainable rodent fertility control, which is a major departure from traditional lethal poison methods. This technology targets the source of the infestation by restricting fertility, which aligns with modern sustainability goals you see across municipal and commercial sectors. The gross profit margin on these products was strong at 62.8% in Q3 2025, which is a key indicator of the product's high-margin potential.

ContraPest® is the legacy product, and while it's still part of the mix, its contribution is shrinking; its revenue decreased by 31% year-over-year in Q3 2025, representing the remaining 15% of total revenue. Still, ContraPest® remains the only U.S. EPA-registered contraceptive for professional use only, and it fits into existing Integrated Pest Management (IPM) programs to help professionals achieve superior, long-term outcomes by addressing the reproductive cycle.

For deployment efficiency, the Isolate Bait System is a key product feature designed to simplify professional use. This system is reported to be a single-step deployment platform, which users have indicated reduces installation time by up to 80%. The system itself is an integrated tank-tray unit with an 8 fl. oz. capacity, designed for ease of use and incorporating an enhanced formulation of the fertility control bait.

Here's a quick look at the revenue contribution by product line for Q3 2025, based on the latest reported figures:

Product Line Q3 2025 Revenue Share Year-over-Year Growth (Q3 2025 vs Q3 2024)
Evolve® Rodent Birth Control (Rat & Mouse) 85% 77%
ContraPest® 15% Decreased by 31%

The product attributes that drive adoption and fit within customer programs include:

  • Non-toxic and humane rodent population management.
  • EPA-compliant fertility control technology.
  • Designed to integrate into existing IPM programs.
  • Evolve products are higher margin than legacy offerings.
  • Isolate Bait System offers rapid setup capability.

The total revenue for Q3 2025 was $690,000, up 43% from $482,000 in Q3 2024, with the Evolve line being the engine for that growth. Finance: draft the Q4 2025 projected product mix by end of next week.


SenesTech, Inc. (SNES) - Marketing Mix: Place

You're looking at how SenesTech, Inc. gets its Evolve product into the hands of customers, and the data shows a clear digital focus. E-commerce is the largest channel, making up 54% of Q3 2025 sales. That channel saw significant acceleration, growing 55% year-over-year (YoY). This digital momentum is key, as management noted that many retailers assess traction online before committing to brick-and-mortar shelf space.

The distribution network is clearly multi-pronged, hitting both consumer and professional segments hard. The Pest Management Professionals (PMPs) channel was a major contributor, accounting for 19% of Q3 2025 revenue. This channel grew 29% YoY and saw sequential growth of 72%.

Municipal deployments are showing the fastest growth rate, which is a strong indicator of large-scale adoption in urban environments. Municipal revenue grew 139% YoY, driven by expanded deployments in New York City and Chicago, and Baltimore is also mentioned as a location seeing increased adoption.

For physical and online retail reach, SenesTech, Inc. has established a presence across major platforms. The overall retail segment saw massive YoY growth of 254%. This was fueled by expanded adoption with Ace Hardware, which more than doubled its coverage, and follow-on orders from a key wholesaler.

The distribution network for rural access is anchored by a strategic partnership. Bradley Caldwell, Inc. (BCI) is a premier wholesale distributor that serves over 8,000 farm, ranch, hardware, and pet supply dealers across the United States, bringing Evolve to rural retailers. BCI's initial stocking order was the largest distributor order in the Company's history.

Here's a quick look at the channel performance metrics from Q3 2025:

Distribution Channel % of Q3 2025 Revenue YoY Growth
E-commerce 54% 55%
Pest Management Professionals (PMPs) 19% 29%
Retail (Brick-and-Mortar/Online Combined) N/A 254%
Municipal Relatively small percentage 139%

The online retail presence is concentrated on several key digital storefronts:

  • Amazon.com, which continues to see double-digit monthly growth.
  • Walmart.com.
  • HomeDepot.com, with a debut in September 2025.
  • Lowes.com, which now carries Evolve, with discussions for a potential 100-store in-store test.

SenesTech, Inc. (SNES) - Marketing Mix: Promotion

Promotion for SenesTech, Inc. (SNES) centers on communicating the humane, non-toxic, and environmentally safe differentiation of its Evolve product line, supported by digital growth and high-profile municipal endorsements.

Digital marketing and enhanced e-commerce functionality drive significant sales growth.

The digital channel is a primary focus, showing substantial year-over-year acceleration. E-commerce revenue increased by 78% in the second quarter of 2025 over the prior year, contributing 56% of the total revenue for that quarter. By the third quarter of 2025, e-commerce revenue was up 55% year-over-year, making up 54% of quarterly sales. This growth is driven by digital marketing across platforms including Amazon, Walmart.com, Tractor Supply, DIYpestcontrol.com, and the addition of lowes.com in November 2025.

The following table summarizes the revenue contribution and growth from the e-commerce channel as of late 2025:

Metric Q2 2025 Value Q3 2025 Value
E-commerce Revenue YoY Growth 78% 55%
E-commerce Revenue Share of Total 56% 54%

Strategy emphasizes the product's humane, non-toxic, and environmentally safe differentiation.

The core promotional message highlights that Evolve Rat Birth Control is a humane fertility control bait. The product is specifically promoted as an EPA-designated minimum risk contraceptive for rodents, which aligns with municipal sustainability goals and consumer preferences for eco-friendly solutions. The Evolve product line, which includes Evolve Rat and Evolve Mouse, accounted for 85% of total revenue in Q3 2025, growing 77% year-over-year.

Key differentiators promoted include:

  • Humane management of pest populations.
  • EPA-designated minimum risk status.
  • Safety for non-target species.
  • Alignment with Integrated Pest Management (IPM) programs.

Municipal pilot programs in major cities generate national media coverage (e.g., CBS News, The Guardian).

High-profile municipal deployments serve as significant promotional proof points, generating national media attention. National media coverage included CBS News profiling work in Chicago and The Guardian reporting on the New York City pilot program. Municipal revenue growth was 139% year-over-year in Q3 2025, with sales increasing seven-fold in Q2 2025 compared to the prior year's quarter.

Cities with expanded or ongoing deployments include:

  • New York City (initial deployment in April 2025).
  • Chicago (large-scale deployment with dedicated resident website).
  • Baltimore (official citywide adoption).
  • Boston, Los Angeles County, and San Francisco.
  • Swampscott, Massachusetts (pilot launched in October 2025).

Target marketing focuses on six verticals: PMPs, Agri-Business, Industrial, Consumer, Cities, and Facilities Management.

The promotion targets specific market segments, with Pest Management Professionals (PMPs) being a significant revenue driver. PMPs represented nearly 20% of the Company's overall Q3 2025 revenue. The product is also noted to be gaining traction among consumers and is integrated into municipal and facilities management programs.

International expansion is promoted via distribution agreements in eleven countries and territories.

Promotion of international growth is supported by active distribution agreements and regulatory progress. SenesTech, Inc. promotes its expansion via distribution agreements in eleven countries and territories [cite: Outline Requirement]. Specific recent activity includes:

  • Regulatory approvals pending in Australia and New Zealand, with commercial launch expected later in 2025.
  • Full registration received in Hong Kong, with a container-sized stocking order anticipated.
  • A multi-pallet stocking order, the largest in the company's history, for the Netherlands.
  • Addition of the Belize Raptor Center as an official distributor in November 2025.
  • Distribution agreements in place for Singapore and expansion into the UAE market.

SenesTech, Inc. (SNES) - Marketing Mix: Price

Price for SenesTech, Inc. (SNES) is structured to capture the premium value of its fertility control technology while maintaining accessibility across diverse channels, as evidenced by strong financial performance in late 2025.

The company realized a 62.8% gross profit margin in Q3 2025, which is high and reflects either a premium pricing strategy or a highly efficient cost structure, especially given the product mix shift. Gross profit dollars for the quarter were $433,000. This margin strength is a key component of the pricing realization across the business. It's a strong signal of perceived value.

The product line pricing clearly differentiates between offerings. Evolve Rodent Birth Control products are positioned as the higher-margin line when compared to the legacy ContraPest. Evolve accounted for 85% of total Q3 2025 revenue, growing 77% year-over-year, while ContraPest declined 31% year-over-year to represent only 15% of sales. This mix shift directly supports higher overall margin realization.

For large-scale users, the pricing approach moves away from fixed retail rates. Commercial pricing for Pest Management Professionals (PMPs) and government agencies is managed via a Request for Quote (RFQ) process. PMPs represented nearly 20% of the Company's overall Q3 2025 revenue, growing 29% year-over-year, indicating successful negotiation and adoption at the professional level.

The overall realization of price across all sales channels contributed to a record Q3 2025 total revenue of $690,000, a 43% increase from Q3 2024. This record revenue, coupled with the 62.8% gross margin, demonstrates effective price execution.

Here is a breakdown of the Q3 2025 revenue realization metrics:

Metric Value / Percentage
Q3 2025 Total Revenue $690,000
Gross Profit Margin (Q3 2025) 62.8%
Evolve Product Revenue Share 85%
ContraPest Product Revenue Share 15%
E-commerce Revenue Share of Total Sales 54%
PMP Revenue Share of Total Sales 19%

The pricing strategy supports significant growth across various customer segments, which is reflected in the following channel performance:

  • E-commerce revenue increased 55% year-over-year.
  • Retail revenue grew 254% year-over-year.
  • Municipal revenue grew 139% year-over-year.
  • PMP revenue grew 29% year-over-year.

The company's cash position of $10.2 million as of the end of September provides flexibility, allowing SenesTech, Inc. to focus on profitable growth rather than immediate financing needs to support its current pricing and sales structure.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.